Search for other papers by Peter D Mark in
Google Scholar
PubMed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Claus L Petersen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Background Subclinical hyperthyroidism (SH) is defined by the biochemical pattern of reduced or undetectable serum thyroid-stimulating hormone (TSH) levels and thyroid hormone levels within the reference range. SH is seen with increasing frequency
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
the impact of overt and subclinical hyperthyroidism on the cardiovascular system. We will thereafter present the latest insights on the cardiac effects of thyroid suppression therapy for the treatment of thyroid cancer. Finally, we will show new
Search for other papers by L E Zijlstra in
Google Scholar
PubMed
Search for other papers by D M van Velzen in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
Search for other papers by S P Mooijaart in
Google Scholar
PubMed
Department of Internal Medicine, HagaHospital, The Hague, The Netherlands
Search for other papers by M van Buren in
Google Scholar
PubMed
Search for other papers by D J Stott in
Google Scholar
PubMed
Search for other papers by I Ford in
Google Scholar
PubMed
Search for other papers by J W Jukema in
Google Scholar
PubMed
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by S Trompet in
Google Scholar
PubMed
Introduction Subclinical hyperthyroidism has been linked to atrial fibrillation and coronary artery calcification, whereas subclinical hypothyroidism has been associated with hypercholesterolemia and atherosclerosis ( 1 , 2 ). Despite these
Search for other papers by Xingyao Tang in
Google Scholar
PubMed
Search for other papers by Zhi-Hui Song in
Google Scholar
PubMed
Search for other papers by Dawei Wang in
Google Scholar
PubMed
Search for other papers by Jinkui Yang in
Google Scholar
PubMed
Search for other papers by Marly Augusto Cardoso in
Google Scholar
PubMed
Search for other papers by Jian-Bo Zhou in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Search for other papers by Rafael Simó in
Google Scholar
PubMed
factor for dementia, promotes neurocognitive function and regulation metabolic processes ( 4 ). Thyroid dysfunction, including clinical hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, and clinical hypothyroidism, has been
Search for other papers by Xin He in
Google Scholar
PubMed
Search for other papers by Qin Yan in
Google Scholar
PubMed
Search for other papers by Chazhen Liu in
Google Scholar
PubMed
Search for other papers by Zhengyuan Wang in
Google Scholar
PubMed
Search for other papers by Ping Liao in
Google Scholar
PubMed
Search for other papers by Tong Liu in
Google Scholar
PubMed
Search for other papers by Zehuan Shi in
Google Scholar
PubMed
Search for other papers by Qi Song in
Google Scholar
PubMed
Search for other papers by Xueying Cui in
Google Scholar
PubMed
Search for other papers by Wenjing Wang in
Google Scholar
PubMed
Search for other papers by Jiajie Zang in
Google Scholar
PubMed
hyperthyroidism was defined as TSH concentration below the 2.5th percentile with an FT4 concentration above the 97.5thpercentile, while subclinical hyperthyroidism was defined as TSH concentration below the 2.5th percentile with an FT4 concentration within the
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan
Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Search for other papers by Antje Steveling in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
results of our study may stress that not only subclinical hypothyroidism but also hyperthyroidism is associated with increased hepatic fat particularly in obese individuals. However, one has to be cautious with these findings, and our results have to be
Search for other papers by Akinori Sairaku in
Google Scholar
PubMed
Search for other papers by Yukiko Nakano in
Google Scholar
PubMed
Search for other papers by Yuko Uchimura in
Google Scholar
PubMed
Search for other papers by Takehito Tokuyama in
Google Scholar
PubMed
Search for other papers by Hiroshi Kawazoe in
Google Scholar
PubMed
Search for other papers by Yoshikazu Watanabe in
Google Scholar
PubMed
Search for other papers by Hiroya Matsumura in
Google Scholar
PubMed
Search for other papers by Yasuki Kihara in
Google Scholar
PubMed
), we hypothesized that subclinical hypothyroidism was associated with an increased LA pressure. It is well known that hyperthyroidism often causes atrial fibrillation (AF) ( 1 , 2 ), and recently, a study ( 10 ) has provided evidence supporting the
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
failure. These early observations have later been corroborated in large observational studies including non-exposed controlled groups ( 52 , 53 , 54 ). On the other hand, subclinical hyperthyroidism has not been associated with a risk of pregnancy
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
-Albright syndrome (MAS), a sporadic genetic disease, is caused by an activating mutation of GNAS1 for the Gs alpha membrane-associated protein, mediating the TSH-induced and other hormone-induced activation of adenylyl cyclase; subclinical hyperthyroidism can be
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Laura Salmaso in
Google Scholar
PubMed
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Pediatric Endocrinology Unit, Department of Women's and Children's Health, Padua University Hospital, Padova, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by Mario Saia in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
associated with nodular goiter is quite well understood and thus the decrease in nodular goiter incidence with the improvement of iodine status is expected. The mechanism is slow and could take decades to go from euthyroidism to subclinical hyperthyroidism